-
Briefly Describe the Therapeutic Targets for Pharmacological Treatment of Nonalcoholic Steatohepatitis (NASH)
Xiaonisha
August 25, 2025
The pathogenesis of metabolic associated steatohepatitis (MASH, formerly known as NASH) is complex, leading to a relatively large number of drug development targets.
-
Fenugreek Extract Approved in Canada, Potentially Becoming a Boon for Women's Health
Xiaonisha
August 19, 2025
Recently, Libifem®, a standardized fenugreek extract from the American company Gencor, has claimed to have received approval from Health Canada.
-
Research Progress in the Extraction, Structural Derivation, and Nano-delivery System of Naringenin
Xiaomichong
July 23, 2025
Naringenin is the aglycone obtained by hydrolyzing a molecule of glucose and rhamnose from naringin. Its structural formula is shown below, belonging to the dihydroflavonoid compound.
-
What Is PGE (Prostaglandin) And the Effects of Prostaglandins
PharmaSources
January 02, 2024
Prostaglandins are lipid molecules that act as local chemical messengers in the body. They have a wide range of functions, influencing nearly every physiological system.
-
VAV Life Sciences ramps up production of crucial lipid ingredients needed for amphotericin-B
expresspharma
May 26, 2021
VAV expects with an increased capacity, its lipid raw materials will help pharma companies to add three lakh vials of liposomal amphotericin-B, by August, and six lakh vials by December 2021.
-
Merck and BioNTech to boost lipid supply for Covid-19 vaccine production
pharmaceutical-technology
February 09, 2021
Merck and BioNTech have announced a further expansion of their strategic partnership to accelerate the supply of urgently needed lipids and boost the amount of their delivery by the year-end.
-
High-Intensity Lipid Lowering May Aid Very Elderly After ACS
drugs
August 07, 2019
Among patients hospitalized for acute coronary syndrome (ACS), the greatest benefit from simvastatin-ezetimibe compared with simvastatin alone to lower lipid levels was observed in those 75 years of age or older...
-
Nonfasting Lipid Levels Adequate for Assessing Cardiovascular Risk
drugs
June 03, 2019
Nonfasting Lipid Levels Adequate for Assessing Cardiovascular Risk.